Afya Limited (NASDAQ:AFYA - Get Free Report) CEO Virgilio Deloy Capobian Gibbon sold 770 shares of the company's stock in a transaction on Monday, April 6th. The shares were sold at an average price of $14.91, for a total transaction of $11,480.70. Following the completion of the transaction, the chief executive officer owned 108,448 shares of the company's stock, valued at approximately $1,616,959.68. The trade was a 0.71% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website.
Virgilio Deloy Capobian Gibbon also recently made the following trade(s):
- On Thursday, April 2nd, Virgilio Deloy Capobian Gibbon sold 20,900 shares of Afya stock. The shares were sold at an average price of $14.94, for a total transaction of $312,246.00.
- On Wednesday, April 1st, Virgilio Deloy Capobian Gibbon sold 19,500 shares of Afya stock. The shares were sold at an average price of $14.98, for a total transaction of $292,110.00.
- On Tuesday, March 31st, Virgilio Deloy Capobian Gibbon sold 2,320 shares of Afya stock. The shares were sold at an average price of $14.92, for a total transaction of $34,614.40.
- On Thursday, March 26th, Virgilio Deloy Capobian Gibbon sold 800 shares of Afya stock. The shares were sold at an average price of $15.21, for a total transaction of $12,168.00.
- On Wednesday, March 25th, Virgilio Deloy Capobian Gibbon sold 3,900 shares of Afya stock. The shares were sold at an average price of $15.18, for a total transaction of $59,202.00.
Afya Trading Up 0.2%
Shares of Afya stock opened at $14.99 on Tuesday. The company has a fifty day simple moving average of $14.48 and a 200-day simple moving average of $14.70. Afya Limited has a 12-month low of $13.00 and a 12-month high of $19.90. The company has a current ratio of 2.20, a quick ratio of 0.98 and a debt-to-equity ratio of 0.21. The stock has a market cap of $1.40 billion, a price-to-earnings ratio of 10.27, a PEG ratio of 0.67 and a beta of 0.48.
Afya (NASDAQ:AFYA - Get Free Report) last issued its earnings results on Wednesday, March 11th. The company reported $0.41 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.36 by $0.05. Afya had a net margin of 20.31% and a return on equity of 18.77%. The business had revenue of $147.08 million during the quarter, compared to analysts' expectations of $174.74 million. On average, equities analysts forecast that Afya Limited will post 1.52 EPS for the current fiscal year.
Afya Announces Dividend
The business also recently announced an annual dividend, which was paid on Monday, April 6th. Stockholders of record on Wednesday, March 25th were issued a $0.656 dividend. The ex-dividend date was Wednesday, March 25th. This represents a dividend yield of 433.0%. Afya's dividend payout ratio is presently 45.21%.
Institutional Trading of Afya
Several hedge funds have recently made changes to their positions in the company. XTX Topco Ltd acquired a new stake in shares of Afya in the 4th quarter worth $215,000. Mangrove Partners IM LLC acquired a new stake in shares of Afya in the 4th quarter worth $197,000. State Street Corp lifted its stake in shares of Afya by 25.8% in the 4th quarter. State Street Corp now owns 126,914 shares of the company's stock worth $1,955,000 after acquiring an additional 26,005 shares during the period. Campbell & CO Investment Adviser LLC lifted its stake in shares of Afya by 45.3% in the 4th quarter. Campbell & CO Investment Adviser LLC now owns 39,683 shares of the company's stock worth $612,000 after acquiring an additional 12,365 shares during the period. Finally, Banco BTG Pactual S.A. acquired a new stake in shares of Afya in the 4th quarter worth $462,000. Institutional investors and hedge funds own 88.02% of the company's stock.
Analyst Ratings Changes
A number of analysts recently weighed in on AFYA shares. Bank of America cut shares of Afya from a "buy" rating to a "neutral" rating and decreased their price target for the stock from $22.00 to $17.00 in a research note on Tuesday, February 24th. Zacks Research upgraded shares of Afya from a "strong sell" rating to a "hold" rating in a research note on Monday, March 9th. UBS Group reiterated a "neutral" rating and set a $16.00 price target (down from $18.00) on shares of Afya in a research note on Friday, January 16th. Weiss Ratings reiterated a "hold (c)" rating on shares of Afya in a research note on Wednesday, January 21st. Finally, Wall Street Zen upgraded shares of Afya from a "buy" rating to a "strong-buy" rating in a research note on Saturday, March 14th. One equities research analyst has rated the stock with a Buy rating and seven have given a Hold rating to the company's stock. According to MarketBeat, the company currently has a consensus rating of "Hold" and an average target price of $17.30.
Read Our Latest Stock Analysis on AFYA
About Afya
(
Get Free Report)
Afya Ltd. operates as a leading provider of medical education and training services in Brazil. The company offers a comprehensive suite of educational programs that span undergraduate medical degrees, residency exam preparation, continuing medical education (CME) and digital learning platforms. Through a network of partner institutions and its own campus operations, Afya supports students at every stage of the medical training continuum, from enrollment in medical schools to ongoing professional development for practicing physicians.
At the core of Afya's offerings is its undergraduate medical program, delivered through a combination of in-person courses at affiliated campuses and fully digital curricula.
Read More
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
